about
Antiplatelet and anticoagulant agents for preventing recurrence of peripheral vascular thrombosis in patients with Antiphospholipid syndromeWarfarin interaction with Matricaria chamomillaChloramphenicol is a potent inhibitor of cytochrome P450 isoforms CYP2C19 and CYP3A4 in human liver microsomesEffect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjectsEvidence of an interaction between nifedipine and nafcillin in humansRoles of rifampicin in drug-drug interactions: underlying molecular mechanisms involving the nuclear pregnane X receptor.Neuroprotective Activity of Hypericum perforatum and Its Major ComponentsClinical pharmacokinetics and pharmacodynamics of the endothelin receptor antagonist macitentanPharmacogenetic-guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumonWarfarin pharmacogenetics: does more accurate dosing benefit patients?Multiple UDP-glucuronosyltransferases in human liver microsomes glucuronidate both R- and S-7-hydroxywarfarin into two metabolites.Crystal structure of human cytochrome P450 2C9 with bound warfarinPharmacogenomics and personalized medicine: a review focused on their application in the Chinese populationThe effects of lacidipine on the steady/state plasma concentrations of simvastatin in healthy subjectsRhabdomyolysis and acute renal failure due to combination therapy with simvastatin and warfarinWarfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groupsA case of intolerance to warfarin dosing in an intermediate metabolizer of CYP2C9Warfarin Pharmacogenetics: New Life for an Old DrugA multiscale approach to modelling drug metabolism by membrane-bound cytochrome P450 enzymesInfluence of sampling on the determination of warfarin and warfarin alcohols in oral fluidComputational tools and resources for metabolism-related property predictions. 1. Overview of publicly available (free and commercial) databases and softwareGenetic factors associated with patient-specific warfarin dose in ethnic IndonesiansClinical and genetic determinants of warfarin pharmacokinetics and pharmacodynamics during treatment initiationAn S-warfarin and AZD1981 interaction: in vitro and clinical pilot data suggest the N-deacetylated amino acid metabolite as the primary perpetrator.Use of in vitro drug metabolism data to evaluate metabolic drug-drug interactions in man: the need for quantitative databases.Implications of cytochrome P450 2C9 polymorphism on warfarin metabolism and dosing.Pharmacokinetic interactions of drugs with St John's wort.Riociguat (BAY 63-2521) and warfarin: a pharmacodynamic and pharmacokinetic interaction study.10 years of oral anticoagulant pharmacogenomics: what difference will it make? A critical appraisal.Salvia miltiorrhiza Roots against Cardiovascular Disease: Consideration of Herb-Drug InteractionsHydroxywarfarin metabolites potently inhibit CYP2C9 metabolism of S-warfarin.Identification of hydroxywarfarin binding site in human UDP glucuronosyltransferase 1a10: phenylalanine90 is crucial for the glucuronidation of 6- and 7-hydroxywarfarin but not 8-hydroxywarfarinAssessing cytochrome P450 and UDP-glucuronosyltransferase contributions to warfarin metabolism in humans.Time-dependent inhibition (TDI) of CYP3A4 and CYP2C9 by noscapine potentially explains clinical noscapine-warfarin interaction.Review article: cytochrome P450 and the metabolism of proton pump inhibitors--emphasis on rabeprazole.Warfarin-acetaminophen drug interaction revisited.Pharmacogenetics of warfarin: challenges and opportunities.Evaluation of risk factors in patients with vitamin K-dependent coagulopathy presumed to be caused by exposure to brodifacoum.Drug interactions with clinafloxacin.CYP2C9 and VKORC1 genotypes in Puerto Ricans: A case for admixture-matching in clinical pharmacogenetic studies.
P2860
Q24185813-38DE938B-BDA1-444C-B9C8-60D38F8A60D3Q24542494-4558D757-8D72-4DD7-BF0B-D9197B9A31E3Q24650578-DCB37445-C079-47C8-A917-B176C8190C68Q24678775-E6F1A7A4-8ECE-431E-9DE3-672662582922Q24679446-BAA2E211-1266-4CA1-9BEC-52350D7DF1CBQ25255438-9EAC0F44-DDB4-4D03-8A77-60460D399979Q26741405-482B48C6-F504-421F-9601-86A4E3E953C9Q26851546-A85FAA4E-C4EC-430B-92AD-FD7A58DF42A1Q27006860-BC902772-6C96-4AE3-B0A1-9F3CCA417FEEQ27027304-5C0A95A7-FEFF-42DD-BA43-AA27837A748BQ27334876-1515CF42-332C-410B-8D61-EEE3353CCDD8Q27641685-0F980FF9-94DA-4503-9A11-7AFBE8E8BE13Q28083875-FA1DEAB4-2A88-4037-B43D-D222821237F6Q28361017-45FBFE67-9D41-4764-B1BC-048B2C8C637CQ28378361-8304004E-5B18-42B7-986C-87843F2C5368Q28395337-D6168F53-0A8F-44F6-9AD4-1CD1CF1CDE4CQ28468645-AF9FDE67-C215-4E31-B1B5-1597CEA33A37Q28468726-7999312F-48D0-4BE8-984E-2E62D427BCD9Q28540804-7FFE8B79-4139-478D-857C-1532D9A1413BQ28542544-818CA718-EAEB-460D-9177-8A80DEF028DEQ28659783-83237B54-355F-485D-B966-6AB70D49DA1CQ31016306-79C34CFD-5049-489F-A9A3-2865C37FE8F6Q31042226-525106BB-6E61-4817-84DF-4F4963AD2EA4Q31123470-EE382204-A31A-4FA7-BE45-9CF2BA5CD5D8Q31900846-0377A035-243C-4764-AF24-705D4DDC5B71Q32049910-1A9CD404-7AAD-4FD5-B36B-40CCBA65E830Q33204911-9FEFEB86-1364-4816-B2BA-65BDF265B621Q33447738-ACAFCEAE-EA74-41AE-9373-C6D131C2297FQ33517162-D323D55D-DC8F-4B6D-B3E6-12EBFBBCB85FQ33572234-361C938D-DC26-480F-9EB6-0AA1798A7EFAQ33606800-4916D89B-BE85-4649-B40A-D89A23428CD8Q33614759-7F5AF6E6-7D96-4FF7-B5A5-501F5C801B4EQ33644101-62C9C54B-354D-4111-8BA0-3C138C95D8D8Q33668240-295177D8-35DB-4E52-BA8B-3389984800EBQ33734852-57AAF830-CA44-4C6B-A4A6-482D8C3341ABQ33747163-5A185B70-606D-47E6-85AF-378E72E385E2Q33819050-6C3BE3F2-9BED-45BC-A39F-CE61395C2CA5Q33912911-D2452756-2419-4EE1-8E80-62705F6C0AC1Q33982922-204AE708-E031-49A7-8497-1AB8764B509BQ33990359-01C86D24-2F02-4315-BEE3-21A7C756018E
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Human P450 metabolism of warfarin.
@en
type
label
Human P450 metabolism of warfarin.
@en
prefLabel
Human P450 metabolism of warfarin.
@en
P1476
Human P450 metabolism of warfarin.
@en
P2093
P356
10.1016/S0163-7258(96)00140-4
P577
1997-01-01T00:00:00Z